LAURA PUGH: Open Payments
NPI 1063931715 · BRYAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,383 in 103 payments from 17 companies in 2025. Trend: 2023 $1,834 · 2024 $1,553 · 2025 $1,383
Food & beverage: $1,383
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 32 | $451 |
| Amgen Inc. | 34 | $203 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $177 |
| Alnylam Pharmaceuticals Inc. | 2 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Novo Nordisk Inc | 3 | $58 |
| ABIOMED | 2 | $54 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| Baxter Healthcare | 2 | $43 |
Products named: LEQVIO, REPATHA, LifeVest, Kerendia, JARDIANCE, VERQUVO, ELIQUIS, Hillrom - Carnation Ambulatory Monitor.
Industry payments across TX — which companies pay providers there.
